Issue Brief

Bill Summary - Counterfeit Drug Enforcement Act of 2009

H.R. 2726 - Tim Fagan Law

This issue brief is a summary of H.R. 2726 - The Counterfeit Drug Enforcement Act of 2009, also known as the Tim Fagan Law. The Law increases penalties for the illegal sale or trade of Rx drugs knowingly adulterated or misbranded, or misrepresented as approved. Fines in accordance with Title 18 USC, prison term up to life.

The Pew Prescription Project promotes consumer safety through reforms in the approval, manufacture, and marketing of prescription drugs.

Media Contact: Linda Paris 202.540.6354

Topics: Drug Safety, Health

Project: Drug Safety Project

Media Contact

Tami Holzman

Officer, Communications

202.552.2122